Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Upadacitinib may effectively treat alopecia areata without side effects.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The new delivery method for dutasteride is more effective and has fewer side effects.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.